This was the stock's second consecutive day of gains.

This was the stock's second consecutive day of gains.

FIRDAPSE boosts Catalyst's strong Q1 2025 results, beating forecasts. With 15–20% growth projected, see why analysts rate ...

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

In 2025, the catalyst bins market is estimated to be valued at approximately USD 39,086.58 million. Looking ahead to ...

MRPL granted US patent for innovative i-BB production process, reducing import dependence and boosting pharmaceutical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

High-Performance Catalyst Market The United Kingdom high-performance catalyst market is set for steady growth, driven by green energy initi ...

Scientists create AshPhos, a molecule that makes drug production cheaper and faster by optimizing key carbon-nitrogen bonds.

Innovative technologies are reshaping drug delivery by addressing the limitations of traditional methods and enhancing ...